12 studies found for:    Open Studies | Heart Diseases | UCSD OR UC San Diego OR VA San Diego
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Conditions: Coronary Artery Disease;   Coronary Disease;   Myocardial Ischemia;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Intervention: Procedure: CorPath-assisted Percutaneous Coronary Intervention
2 Recruiting Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
Condition: Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions: Drug: Tafamidis;   Drug: Placebo
3 Not yet recruiting Substrate Versus Trigger Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: FIRM Ablation;   Procedure: Conventional AF ablation with PVI
4 Recruiting The Dynamics of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Tachyarrhythmia
Intervention:
5 Unknown  Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Conditions: Ranolazine;   Diastolic Heart Failure;   Tissue Doppler Ultrasound;   Echocardiography
Intervention: Drug: ranolazine
6 Recruiting AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
Conditions: Atrioventricular Block;   Sick Sinus Syndrome;   Symptomatic Bradycardia;   Cardiac Arrhythmia
Interventions: Device: Long, fixed AV delay;   Device: Short, optimized AV delay
7 Recruiting Nit-Occlud PDA Post-Approval Study
Condition: Patent Ductus Arteriosus (PDA)
Intervention:
8 Recruiting Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation
Conditions: Paroxysmal Atrial Fibrillation;   Atrial Arrhythmia
Interventions: Procedure: Circumferential Pulmonary Vein Ablation;   Procedure: Segmental Pulmonary Vein Isolation
9 Recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
10 Recruiting MAESTRO (Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity)
Condition: Eisenmenger Syndrome
Interventions: Drug: Macitentan 10 mg, oral tablet, to be taken once daily.;   Drug: Matching placebo oral tablet, to be taken once daily.
11 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
12 Recruiting Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
Condition: Portopulmonary Hypertension
Intervention: Drug: Ambrisentan

Indicates status has not been verified in more than two years